Compare Mirae Asset Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹99
₹100
Expense Ratio
1.93
1.86
NAV
₹39.08
₹37.96
Fund Started
11 Jun 2018
25 Jun 2018
Fund Size
₹2639.92 Cr
₹6658.41 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 1% if redeemed within 15 days.
1 Year
12.58%
8.03%
3 Year
24.94%
27.09%
5 Year
15.99%
16.93%
Equity
99.75%
97.60%
Cash
0.25%
2.37%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.11% |
Divi's Laboratories Ltd. | 8.52% |
Glenmark Pharmaceuticals Ltd. | 7.00% |
Apollo Hospitals Enterprise Ltd. | 6.21% |
Lupin Ltd. | 5.54% |
Cipla Ltd. | 5.11% |
Dr. Reddy's Laboratories Ltd. | 4.37% |
Aurobindo Pharma Ltd. | 4.33% |
Fortis Healthcare Ltd. | 4.27% |
JB Chemicals & Pharmaceuticals Ltd. | 3.62% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
11 Jun 2018
25 Jun 2018
